Research Dashboard

All peptides ranked by evidence quality and research progress. Click any peptide to view its full research profile.

130

Total Peptides

High Evidence

Moderate Evidence

Phase 3+ / Approved

446

Studies Indexed

Peptide	Category	Evidence	Status	Studies
Abaloparatide	Musculoskeletal	high	approved	2
Afamelanotide	Skin	high	approved	2
Alprostadil	Vascular	high	approved	5
Botulinum Toxin	Cosmetic	high	approved	2
EPO	Performance	high	approved	4
Exenatide	Metabolic	high	approved	2
GLP-1	Metabolic	high	approved	4
Insulin	Metabolic	high	approved	5
Linaclotide	Healing	high	approved	2
Liraglutide	Metabolic	high	approved	4
Mazdutide	Metabolic	high	approved	6
Melanotan-1	Skin	high	approved	4
Motixafortide	Immune	high	approved	1
Oxytocin	Hormonal	high	approved	6
Pegcetacoplan	Immune	high	approved	2
Pramlintide (Symlin)	Metabolic	high	approved	2
PT-141	Reproductive	high	approved	5
Semaglutide	Metabolic	high	approved	4
Setmelanotide (IMCIVREE)	Metabolic	high	approved	2
Teduglutide	Healing	high	approved	4
Teriparatide	Musculoskeletal	high	approved	2
Tesamorelin	Growth Hormone	high	approved	4
Tirzepatide	Metabolic	high	approved	4
Triptorelin	Reproductive	high	approved	5
Ziconotide	Pain	high	approved	3
Zilucoplan	Immune	high	approved	3
CagriSema	Metabolic	high	Phase 3	3
Enlicitide Decanoate	Vascular	high	Phase 3	3
Icotrokinra	Skin	high	Phase 3	5
Orforglipron	Metabolic	high	Phase 3	4
Oveporexton	Sleep	high	Phase 3	2
GDF-8	Musculoskeletal	high	preclinical	5
Albiglutide (Tanzeum)	Metabolic	high	discontinued	2
Cerebrolysin	Neuroprotective	moderate	approved	5
GHRP-2	Growth Hormone	moderate	approved	3
Matrixyl	Skin	moderate	approved	2
Semax	Cognitive	moderate	approved	8
Sermorelin	Growth Hormone	moderate	approved	5
SS-31	Mitochondrial	moderate	approved	4
Thymosin Alpha-1	Immune	moderate	approved	4
Amycretin	Metabolic	moderate	Phase 3	3
Apitegromab	Musculoskeletal	moderate	Phase 3	3
Cagrilintide	Metabolic	moderate	Phase 3	4
Ecnoglutide	Metabolic	moderate	Phase 3	3
Eloralintide	Metabolic	moderate	Phase 3	3
Glepaglutide	Healing	moderate	Phase 3	3
IO102-IO103	Immune	moderate	Phase 3	2
MariTide	Metabolic	moderate	Phase 3	2
Ribupatide	Metabolic	moderate	Phase 3	3
Rusfertide	Immune	moderate	Phase 3	1
Survodutide	Metabolic	moderate	Phase 3	2
VK2735	Metabolic	moderate	Phase 3	3
Aleniglipron	Metabolic	moderate	Phase 2	2
ARA-290	Neuroprotective	moderate	Phase 2	3
Bimagrumab	Musculoskeletal	moderate	Phase 2	3
Carnosine	Anti-Aging	moderate	Phase 2	4
CT-388	Metabolic	moderate	Phase 2	2
Enobosarm	Musculoskeletal	moderate	Phase 2	3
Follistatin	Musculoskeletal	moderate	Phase 2	3
Hexarelin	Growth Hormone	moderate	Phase 2	4
Ibutamoren (MK-677)	Growth Hormone	moderate	Phase 2	3
Kisspeptin	Hormonal	moderate	Phase 2	5
LIB-01	Reproductive	moderate	Phase 2	4
MVT-602	Reproductive	moderate	Phase 2	2
NAD+	Anti-Aging	moderate	Phase 2	6
Nomlabofusp	Neuroprotective	moderate	Phase 2	2
Pemvidutide	Metabolic	moderate	Phase 2	3
Risuteganib	Healing	moderate	Phase 2	2
TB500	Healing	moderate	Phase 2	10
Trevogrumab	Musculoskeletal	moderate	Phase 2	3
Neuropeptide Y	Neuropeptide	moderate	Phase 1	2
Argireline	Cosmetic	moderate	preclinical	2
GHRP-6	Growth Hormone	moderate	preclinical	4
Glutathione	Immune	moderate	preclinical	5
ACE-031	Musculoskeletal	moderate	discontinued	2
AOD-9604	Metabolic	moderate	discontinued	4
Brimapitide	Healing	moderate	discontinued	2
CJC-1295 DAC	Growth Hormone	moderate	discontinued	3
Cotadutide (MEDI0382)	Metabolic	moderate	discontinued	2
Davunetide	Neuroprotective	moderate	discontinued	1
Gonadorelin	Reproductive	moderate	discontinued	3
Larazotide	Immune	moderate	discontinued	3
Nemifitide	Neuropeptide	moderate	discontinued	3
Rapastinel	Neuropeptide	moderate	discontinued	2
Taspoglutide	Metabolic	moderate	discontinued	3
HCG	Reproductive	low	approved	6
HGH 191AA	Growth Hormone	low	approved	5
HMG	Reproductive	low	approved	5
Selank	Cognitive	low	approved	4
Thymalin	Immune	low	approved	4
Bioglutide (NA-931)	Metabolic	low	Phase 3	4
MET-097i	Metabolic	low	Phase 3	2
Retatrutide	Metabolic	low	Phase 3	3
Bivamelagon	Metabolic	low	Phase 2	1
Ipamorelin	Growth Hormone	low	Phase 2	3
LL-37	Immune	low	Phase 2	7
Petrelintide	Metabolic	low	Phase 2	3
PP405	Skin	low	Phase 2	2
VIP	Neuropeptide	low	Phase 2	4
Zovaglutide	Metabolic	low	Phase 2	1
GUBamy	Metabolic	low	Phase 1	2
5-Amino-1MQ	Anti-Aging	low	preclinical	3
Adipotide	Metabolic	low	preclinical	4
BPC-157	Healing	low	preclinical	4
CJC-1295 without DAC	Growth Hormone	low	preclinical	2
Cortistatin	Sleep	low	preclinical	3
Dermorphin	Pain	low	preclinical	5
Dihexa	Cognitive	low	preclinical	2
DSIP	Sleep	low	preclinical	5
GHK-Cu	Healing	low	preclinical	3
HGH Fragment 176-191	Growth Hormone	low	preclinical	5
Humanin	Anti-Aging	low	preclinical	3
Klotho Peptides	Anti-Aging	low	preclinical	4
Melanotan-2	Skin	low	preclinical	3
MGF	Growth Hormone	low	preclinical	8
MOTS-c	Mitochondrial	low	preclinical	3
OS-01 (Peptide 14)	Anti-Aging	low	preclinical	4
PE-22-28	Neuropeptide	low	preclinical	2
Pinealon	Cognitive	low	preclinical	6
PNC-27	Anti-Aging	low	preclinical	6
SNAP-8	Skin	low	preclinical	4
Tat-Beclin-1	Anti-Aging	low	preclinical	3
Vilon	Anti-Aging	low	preclinical	2
Epitalon	Anti-Aging	very low	preclinical	4
FOXO4-DRI	Anti-Aging	very low	preclinical	1
IGF-1 DES	Growth Hormone	very low	preclinical	3
IGF-1 LR3	Growth Hormone	very low	preclinical	3
KPV	Immune	very low	preclinical	4
PEG-MGF	Growth Hormone	very low	preclinical	5
Cebranopadol	Pain	moderate high	Phase 3	5